$LFST
LifeStance Health Group, Inc.

2022 Q1 Form 10-K Financial Statement

#000095017022004096 Filed on March 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $203.1M $190.0M $667.5M
YoY Change 41.89% 60.85% 76.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $103.4M $151.5M $433.7M
YoY Change 216.59% -51.32% 39.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.727M $15.36M $15.09M
YoY Change 119.51% 35.09% -51.38%
% of Gross Profit
Operating Expenses $267.9M $302.6M $953.9M
YoY Change 86.06% 165.07% 163.66%
Operating Profit -$64.85M -$286.4M
YoY Change 7261.07%
Interest Expense $3.441M -$3.602M $38.91M
YoY Change -60.14% -49.47% -275.81%
% of Operating Profit
Other Income/Expense, Net -$4.153M -$1.171M -$46.75M
YoY Change -60.68% 44.39% 8704.52%
Pretax Income -$69.00M -$118.6M -$333.1M
YoY Change 503.02% 1578.76% 650.05%
Income Tax -$6.676M -$10.61M -$25.91M
% Of Pretax Income
Net Earnings -$62.33M -$108.0M -$307.2M
YoY Change 617.9% 1868.12% 706.93%
Net Earnings / Revenue -30.69% -56.86% -46.02%
Basic Earnings Per Share
Diluted Earnings Per Share -$177.6K -$312.0K -$937.9K
COMMON SHARES
Basic Shares Outstanding 374.3M 374.1M 327.5K
Diluted Shares Outstanding 350.8K 327.5K

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.0M $148.0M $148.0M
YoY Change 188.63% 686.18%
Cash & Equivalents $114.0M $148.0M $148.0M
Short-Term Investments
Other Short-Term Assets $54.32M $4.342M $23.80M
YoY Change 143.39% 436.05% 126.26%
Inventory
Prepaid Expenses
Receivables $94.99M $76.08M $76.08M
Other Receivables $0.00 $0.00 $18.62M
Total Short-Term Assets $263.3M $266.5M $266.5M
YoY Change 140.28% 249.4% 249.4%
LONG-TERM ASSETS
Property, Plant & Equipment $170.9M $152.2M $152.2M
YoY Change 141.42% 156.52% 156.52%
Goodwill $1.229B $1.205B
YoY Change 9.64%
Intangibles $291.2M $300.4M
YoY Change -9.75%
Long-Term Investments
YoY Change
Other Assets $3.679M $3.448M $3.448M
YoY Change 25.73% 30.26%
Total Long-Term Assets $1.695B $1.661B $1.661B
YoY Change 13.25% 11.19% 11.19%
TOTAL ASSETS
Total Short-Term Assets $263.3M $266.5M $266.5M
Total Long-Term Assets $1.695B $1.661B $1.661B
Total Assets $1.958B $1.927B $1.927B
YoY Change 21.92% 22.77% 22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.14M $14.15M $14.15M
YoY Change 155.98% 84.08% 84.08%
Accrued Expenses $95.01M $26.51M $76.06M
YoY Change 33.78% 80.52% 61.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.323M $1.323M $1.323M
YoY Change -64.61% -64.61%
Total Short-Term Liabilities $125.6M $116.8M $116.8M
YoY Change 29.81% 53.78% 53.78%
LONG-TERM LIABILITIES
Long-Term Debt $177.4M $157.4M $157.4M
YoY Change -54.2% -56.58% -56.58%
Other Long-Term Liabilities $57.49M $50.33M $53.63M
YoY Change 277.14% 342.88% 211.56%
Total Long-Term Liabilities $290.3M $265.3M $211.0M
YoY Change -27.89% -42.44% -44.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $125.6M $116.8M $116.8M
Total Long-Term Liabilities $290.3M $265.3M $211.0M
Total Liabilities $415.9M $382.1M $382.1M
YoY Change -28.36% -28.84% -28.84%
SHAREHOLDERS EQUITY
Retained Earnings -$419.4M -$357.1M
YoY Change 2620.55%
Common Stock $1.962B $1.902B
YoY Change 130898.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.543B $1.545B $1.545B
YoY Change
Total Liabilities & Shareholders Equity $1.958B $1.927B $1.927B
YoY Change 21.92% 22.77% 22.77%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$62.33M -$108.0M -$307.2M
YoY Change 617.9% 1868.12% 706.93%
Depreciation, Depletion And Amortization $5.727M $15.36M $15.09M
YoY Change 119.51% 35.09% -51.38%
Cash From Operating Activities $3.308M $30.63M $9.420M
YoY Change -66.62% 636.42% -210.39%
INVESTING ACTIVITIES
Capital Expenditures $27.91M -$38.68M $94.49M
YoY Change 151.87% 264.57% -348.23%
Acquisitions $22.95M $99.58M
YoY Change 2943.1%
Other Investing Activities -$22.95M -$40.89M -$99.58M
YoY Change 2943.1% -69.5% -87.9%
Cash From Investing Activities -$50.86M -$79.56M -$194.1M
YoY Change 329.7% -44.99% -77.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $331.0K $311.4M
YoY Change -57.83%
Cash From Financing Activities 13.51M -15.17M 313.9M
YoY Change -40.21% -111.3% -65.6%
NET CHANGE
Cash From Operating Activities 3.308M 30.63M 9.420M
Cash From Investing Activities -50.86M -79.56M -194.1M
Cash From Financing Activities 13.51M -15.17M 313.9M
Net Change In Cash -34.04M -64.09M 129.2M
YoY Change -264.72% 927.31% 203.49%
FREE CASH FLOW
Cash From Operating Activities $3.308M $30.63M $9.420M
Capital Expenditures $27.91M -$38.68M $94.49M
Free Cash Flow -$24.60M $69.31M -$85.07M
YoY Change 1999.15% 369.31% -388.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-40478
CY2021 dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
CY2021Q4 us-gaap Assets
Assets
1927109000
CY2021 dei City Area Code
CityAreaCode
602
CY2021 dei Local Phone Number
LocalPhoneNumber
767-2100
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2021 dei Trading Symbol
TradingSymbol
LFST
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1995527802
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
374270967
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
Seattle, WashingtonMarch 17, 2022We have served as the Company's auditor since 2020.
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148029000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18829000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76078000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43706000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42413000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13745000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
266520000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
76280000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59349000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
300355000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
332796000
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
CY2020Q4 us-gaap Goodwill
Goodwill
1098659000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3448000
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2647000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1660589000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1493451000
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
415000
CY2020Q4 us-gaap Assets
Assets
1569731000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14152000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7688000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60002000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38024000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26510000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14685000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
14123000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10563000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1965000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4961000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
116752000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75921000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
157416000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
362534000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50325000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11363000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3307000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5851000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54281000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
81226000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
265329000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
460974000
CY2021Q4 us-gaap Liabilities
Liabilities
382081000
CY2020Q4 us-gaap Liabilities
Liabilities
536895000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
0
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374255000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374255000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3743000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1898357000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1452000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357072000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13125000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1545028000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
997836000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1927109000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1569731000
CY2021 us-gaap Revenues
Revenues
667511000
us-gaap Revenues
Revenues
265556000
us-gaap Revenues
Revenues
111661000
CY2019 us-gaap Revenues
Revenues
212518000
CY2021 us-gaap Other General Expense
OtherGeneralExpense
466003000
us-gaap Other General Expense
OtherGeneralExpense
179264000
us-gaap Other General Expense
OtherGeneralExpense
78777000
CY2019 us-gaap Other General Expense
OtherGeneralExpense
150122000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
433725000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51841000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20854000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41060000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54136000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
27710000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3335000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6095000
CY2021 us-gaap Operating Expenses
OperatingExpenses
953864000
us-gaap Operating Expenses
OperatingExpenses
258815000
us-gaap Operating Expenses
OperatingExpenses
102966000
CY2019 us-gaap Operating Expenses
OperatingExpenses
197277000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-286353000
us-gaap Operating Income Loss
OperatingIncomeLoss
6741000
us-gaap Operating Income Loss
OperatingIncomeLoss
8695000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
15241000
CY2021 lfst Business Combination Remeasurement Gains Loss On Contingent Consideration
BusinessCombinationRemeasurementGainsLossOnContingentConsideration
-2610000
lfst Business Combination Remeasurement Gains Loss On Contingent Consideration
BusinessCombinationRemeasurementGainsLossOnContingentConsideration
-576000
lfst Business Combination Remeasurement Gains Loss On Contingent Consideration
BusinessCombinationRemeasurementGainsLossOnContingentConsideration
322000
CY2019 lfst Business Combination Remeasurement Gains Loss On Contingent Consideration
BusinessCombinationRemeasurementGainsLossOnContingentConsideration
229000
CY2021 lfst Transaction Cost
TransactionCost
3762000
lfst Transaction Cost
TransactionCost
3937000
lfst Transaction Cost
TransactionCost
33247000
CY2019 lfst Transaction Cost
TransactionCost
2186000
CY2021 us-gaap Interest Expense
InterestExpense
38911000
us-gaap Interest Expense
InterestExpense
19112000
us-gaap Interest Expense
InterestExpense
3020000
CY2019 us-gaap Interest Expense
InterestExpense
5409000
CY2021 us-gaap Other Expenses
OtherExpenses
1469000
us-gaap Other Expenses
OtherExpenses
263000
us-gaap Other Expenses
OtherExpenses
14000
CY2019 us-gaap Other Expenses
OtherExpenses
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23888000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35959000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7366000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2206000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46752000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-333105000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17147000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27264000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7875000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-25908000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4022000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2319000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-307197000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13125000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24945000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5669000
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
us-gaap Dividends Preferred Stock
DividendsPreferredStock
662000
CY2019 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1598000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-343947000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13125000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-298189000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58904000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.05
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
327523
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
302335
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997836000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-307197000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
CY2021 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
CY2021 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71750000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-441000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
259439000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0
us-gaap Net Income Loss
NetIncomeLoss
-13125000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21000000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
7590000
lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
511000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1452000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997836000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-166355000
us-gaap Net Income Loss
NetIncomeLoss
-24945000
us-gaap Profit Loss
ProfitLoss
-13125000
us-gaap Profit Loss
ProfitLoss
-24945000
CY2019 us-gaap Profit Loss
ProfitLoss
5669000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54136000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
27710000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3335000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6095000
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
500000
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
272582000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-464382000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-109103000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
5669000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54000
CY2019 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
62975000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-166355000
CY2021 us-gaap Profit Loss
ProfitLoss
-307197000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
259439000
us-gaap Share Based Compensation
ShareBasedCompensation
1452000
us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
54000
CY2021 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-26945000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-4156000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-2345000
CY2019 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1760000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-14440000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3066000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1797000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
759000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
215000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
707000
CY2021 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-2610000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-576000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
322000
CY2019 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
229000
CY2021 lfst Endowment Of Shares
EndowmentOfShares
9000000
lfst Endowment Of Shares
EndowmentOfShares
0
lfst Endowment Of Shares
EndowmentOfShares
0
CY2019 lfst Endowment Of Shares
EndowmentOfShares
0
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24213000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8183000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5122000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5759000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
29121000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1101000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4526000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2233000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
623000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2467000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1638000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2535000
CY2021 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
15265000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
58000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
8753000
CY2019 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
5201000
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
39586000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-31492000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
40031000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3248000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9420000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21969000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13436000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17048000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94492000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25262000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12804000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14314000
CY2021 lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
0
lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
646694000
lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
0
CY2019 lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
0
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
99584000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
164135000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12274000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59061000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194076000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-836091000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25078000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73375000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
548905000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021 lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
0
lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
633585000
lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
0
CY2019 lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
0
CY2021 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1000000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
21000000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0
CY2019 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0
CY2021 lfst Payments For Repurchase Of Redeemable Convertible Preferred Units
PaymentsForRepurchaseOfRedeemableConvertiblePreferredUnits
0
lfst Payments For Repurchase Of Redeemable Convertible Preferred Units
PaymentsForRepurchaseOfRedeemableConvertiblePreferredUnits
0
lfst Payments For Repurchase Of Redeemable Convertible Preferred Units
PaymentsForRepurchaseOfRedeemableConvertiblePreferredUnits
1000000
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1964000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
311390000
CY2019 lfst Payments For Repurchase Of Redeemable Convertible Preferred Units
PaymentsForRepurchaseOfRedeemableConvertiblePreferredUnits
0
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
98800000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
392064000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
74350000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
55938000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2360000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8684000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
650000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
156785000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
18222000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
488000
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
8820000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
12279000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4291000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
19093000
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5023000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
313856000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
876889000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35385000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48463000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
129200000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18829000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23743000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7864000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18829000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3481000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11345000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18829000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27224000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3481000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
22415000
us-gaap Interest Paid Net
InterestPaidNet
14292000
us-gaap Interest Paid Net
InterestPaidNet
2857000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
4582000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
1093000
us-gaap Income Taxes Paid
IncomeTaxesPaid
221000
us-gaap Income Taxes Paid
IncomeTaxesPaid
25000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
254000
CY2021 lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
1438000
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
109000
CY2019 lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
787000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
3788000
CY2021 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
10685000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
10220000
CY2019 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
22868000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
2718000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
7590000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
0
CY2021 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
15845000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
4465000
CY2019 lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
0
CY2021 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
CY2019 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
1249000
CY2021 lfst Issuance Of Series A Redeemable Convertible Preferred Units For Acquisitions Of Businesses
IssuanceOfSeriesARedeemableConvertiblePreferredUnitsForAcquisitionsOfBusinesses
0
lfst Issuance Of Series A Redeemable Convertible Preferred Units For Acquisitions Of Businesses
IssuanceOfSeriesARedeemableConvertiblePreferredUnitsForAcquisitionsOfBusinesses
0
lfst Issuance Of Series A Redeemable Convertible Preferred Units For Acquisitions Of Businesses
IssuanceOfSeriesARedeemableConvertiblePreferredUnitsForAcquisitionsOfBusinesses
0
CY2019 lfst Issuance Of Series A Redeemable Convertible Preferred Units For Acquisitions Of Businesses
IssuanceOfSeriesARedeemableConvertiblePreferredUnitsForAcquisitionsOfBusinesses
5770000
CY2021 lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
0
lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
511000
lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
0
CY2019 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
0
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
441000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2021 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-28
CY2021 lfst Reclassification Of Redeemable Investor Units To Additional Paid In Capital Due To Conversion
ReclassificationOfRedeemableInvestorUnitsToAdditionalPaidInCapitalDueToConversion
71648000
CY2021Q4 lfst Reclassification Of Members Capital Due To Conversion
ReclassificationOfMembersCapitalDueToConversion
1008688000
CY2021 lfst Reclassification Of Common Stock Due To Conversion
ReclassificationOfCommonStockDueToConversion
3408000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Accounting Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in estimates are made when circumstances warrant. Significant estimates and assumptions by management may affect total revenue impacted by variable consideration and discounts, price concessions, allowance for credit losses, the carrying value of long-lived assets (including goodwill and intangible assets), acquisition accounting, the calculation of a contingent liability in connection with an acquisition, the provision for income taxes and related deferred tax accounts, certain accrued liabilities, payor settlements, contingencies, litigation and related legal accruals and the value attributed to employee stock and unit-based awards.</span></p>
CY2021 lfst Schedule Of Depreciation Of Property And Equipment Textblock
ScheduleOfDepreciationOfPropertyAndEquipmentTextblock
<span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation of property and equipment is computed primarily using the straight-line method over the following estimated useful lives:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:77.698%;"/> <td style="width:22.302%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture, fixtures and equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> - </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7 years</span></span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computers and peripherals</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Medical equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7 years</span></span></p></td> </tr> </table>
CY2021Q4 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2021 us-gaap Units Of Partnership Interest Description
UnitsOfPartnershipInterestDescription
According to the terms of the Partnership Interest Award Agreement, 20% of the Class B Units vest on the one year anniversary of May 14, 2020; and the remaining 80% of the Class B Units vest monthly in equal amounts, until fully vested over a five year period starting on the grant date.
us-gaap Advertising Expense
AdvertisingExpense
1942000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
11696000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
87000
us-gaap Advertising Expense
AdvertisingExpense
663000
CY2021 us-gaap General Discussion Of Pension And Other Postretirement Benefits
GeneralDiscussionOfPensionAndOtherPostretirementBenefits
The Company 401(k) Plan provides for a 401(k) matching program under which the Company will match 100% of the employees’ contribution up to 3% of the employees’ compensation, plus 50% of salary deferrals between 3% and 5% of employees’ compensation. The matching contribution is subject to certain eligibility and vesting conditions.
CY2021 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
11375000
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
4231000
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
1819000
CY2019 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
2661000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentrations of Risk and Significant Customers</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and patient accounts receivable. Although the Company deposits its cash with multiple financial institutions in the U.S., its deposits, at times, may exceed federally insured limits. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company does not have any individual customer that exceeded 10% of the Company’s patient accounts receivable balance</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> at December 31, 2021 and 2020 (Successor). Two payors individually exceeded 10% of the Company’s patients accounts receivable balance at December 31, 2021 and 2020 (Successor). These payors comprise </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, of the patient accounts receivable balance, respectively, as of December 31, 2021 (Successor), and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, as of December 31, 2020 (Successor)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"/></span></p>
CY2021 us-gaap Concentration Risk Benchmark Description
ConcentrationRiskBenchmarkDescription
The Company does not have any individual customer that exceeded 10% of the Company’s patient accounts receivable balance at December 31, 2021 and 2020 (Successor). Two payors individually exceeded 10% of the Company’s patients accounts receivable balance at December 31, 2021 and 2020 (Successor). These payors comprise 17% and 19%, of the patient accounts receivable balance, respectively, as of December 31, 2021 (Successor), and 25% and 23%, respectively, as of December 31, 2020 (Successor).
CY2021 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
381823000
CY2021 lfst Business Combination Cash Consideration
BusinessCombinationCashConsideration
670941000
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
4500000
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
126106000
CY2020Q2 us-gaap Goodwill
Goodwill
926658000
CY2021 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
24
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
17
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
6
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
4718000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
5573000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
238000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
6954000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
10371000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
1344000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
887000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
1948000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
234000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
428000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
3415000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
68000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
201000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
521000
CY2021Q4 lfst Prepaid Fixed Fee Bonuses
PrepaidFixedFeeBonuses
6831000
CY2020Q4 lfst Prepaid Fixed Fee Bonuses
PrepaidFixedFeeBonuses
1680000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3135000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
6601000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
11766000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
2080000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
107999000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1702000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
169024000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
14099000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
127788000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
202618000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
18150000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
10088000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
15100000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
1493000
CY2021 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
117700000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
187518000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
16657000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
11766000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2080000
CY2021Q4 lfst Prepaid Clinical Advances
PrepaidClinicalAdvances
4614000
CY2020Q4 lfst Prepaid Clinical Advances
PrepaidClinicalAdvances
4586000
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
4874000
CY2020Q4 us-gaap Prepaid Rent
PrepaidRent
2549000
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
18617000
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
2418000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4342000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
810000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42413000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13745000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
362667000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-62312000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
300355000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
356066000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-23270000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
332796000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39042000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23270000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1435000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3056000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
39775000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
39775000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
27537000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
15992000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
11200000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
166076000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
300355000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
171768000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63781000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19526000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4432000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59349000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15094000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4440000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3039000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
16414000
CY2020Q4 lfst Financial Assets And Liabilities Fair Value Recurring
FinancialAssetsAndLiabilitiesFairValueRecurring
0
CY2021Q4 lfst Financial Assets And Liabilities Fair Value Recurring
FinancialAssetsAndLiabilitiesFairValueRecurring
0
CY2020Q2 us-gaap Goodwill
Goodwill
0
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
2977000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
169024000
CY2020Q4 us-gaap Goodwill
Goodwill
1098659000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
107999000
CY2021 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-2114000
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
CY2021Q4 lfst Patient Credit Payable
PatientCreditPayable
10457000
CY2020Q4 lfst Patient Credit Payable
PatientCreditPayable
7350000
CY2021Q4 lfst Accrual For Goods Received Not Invoiced
AccrualForGoodsReceivedNotInvoiced
5537000
CY2020Q4 lfst Accrual For Goods Received Not Invoiced
AccrualForGoodsReceivedNotInvoiced
0
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3450000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
233000
CY2021Q4 lfst Credit Card Payable
CreditCardPayable
1253000
CY2020Q4 lfst Credit Card Payable
CreditCardPayable
110000
CY2021Q4 lfst Other Accrued Expense
OtherAccruedExpense
5813000
CY2020Q4 lfst Other Accrued Expense
OtherAccruedExpense
6992000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26510000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14685000
CY2020Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2689
CY2020Q2 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
May 14, 2026
CY2021Q2 lfst Voluntary Prepayment Of Borrowings Outstanding
VoluntaryPrepaymentOfBorrowingsOutstanding
294000
CY2021Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
14440
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
161230000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
373820000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1323000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3738000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2491000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7548000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
157416000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
362534000
CY2021 us-gaap Interest Expense
InterestExpense
38911000
us-gaap Interest Expense
InterestExpense
19112000
us-gaap Interest Expense
InterestExpense
3020000
CY2019 us-gaap Interest Expense
InterestExpense
5409000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
1323000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
1323000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
1323000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
1323000
CY2021Q4 lfst Long Term Debt Maturities Repayments Of Principal In Rolling Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearSix
155938000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
161230000
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
186497000
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
458685000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
667511000
CY2021 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
265556000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
111661000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
212518000
CY2019 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
977000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
429000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
251000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
356000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
977000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
429000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
251000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
356000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-19559000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3239000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1592000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1810000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-7326000
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0079
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1212000
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-978000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
40000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-26885000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4451000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2570000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1850000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-25908000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4022000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2319000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2206000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
14909000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3064000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16904000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7784000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5567000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
2567000
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
0
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2609000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
42556000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10849000
CY2021Q4 lfst Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
22785000
CY2020Q4 lfst Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
10200000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
74052000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
81875000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
96837000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
92075000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
54281000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
81226000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-69952000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3601000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-6507000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0195
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-862000
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0503
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
49489000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.1486
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
305000
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.0178
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1062000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0032
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
136000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-25908000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0777
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4022000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2346
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5726000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1653000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-762000
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0280
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
286000
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0363
lfst Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
4204000
lfst Effective Income Tax Rate Transaction Costs
EffectiveIncomeTaxRateTransactionCosts
-0.1542
CY2019 lfst Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
0
CY2019 lfst Effective Income Tax Rate Transaction Costs
EffectiveIncomeTaxRateTransactionCosts
0
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-35000
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0013
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
267000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0296
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2319000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0851
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2206000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2759
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
54000
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
221823000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0014
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0020
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4000
CY2021 lfst Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Liquidity Event
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTimeToLiquidityEvent
P2Y
lfst Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Liquidity Event
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTimeToLiquidityEvent
P3Y
CY2021Q4 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
0
CY2020Q4 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
20.00
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.13
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.13
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.16
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.13
CY2021 lfst Share Based Compensation Arrangement By Share Based Payment Award Options Conversion Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionWeightedAverageGrantDateFairValue
0.13
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Unit Outstanding
CommonUnitOutstanding
0
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1044509000
CY2020Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
1044509000
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1687000
CY2021 lfst Vested Of Common Stock Profit Interest
VestedOfCommonStockProfitInterest
17920000
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
723267000
CY2021 lfst Common Units Initial Public Offering In Period
CommonUnitsInitialPublicOfferingInPeriod
32800000
CY2021 lfst Endowment To The Lifestance Health Foundation
EndowmentToTheLifestanceHealthFoundation
500000
CY2021 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
106000
CY2021Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
374255000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
249805000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30232000
CY2021Q2 lfst Fair Value Of Mezzanine Equity
FairValueOfMezzanineEquity
36750000
CY2021 lfst Number Of Office Facilities
NumberOfOfficeFacilities
41
CY2021 lfst Lease Expiration Year
LeaseExpirationYear
2030
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2763000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
659000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
388000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2462000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2924000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2740000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2491000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2425000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
833000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
743000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12156000
CY2021Q2 lfst Termination Fee
TerminationFee
1213000
us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1445000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14000
CY2020Q4 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
16414000
CY2020Q2 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
0
CY2019Q4 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
25536000
CY2021 lfst Business Combinations Additions Related To Tpg Acquisition
BusinessCombinationsAdditionsRelatedToTPGAcquisition
0
lfst Business Combinations Additions Related To Tpg Acquisition
BusinessCombinationsAdditionsRelatedToTPGAcquisition
9909000
lfst Business Combinations Additions Related To Tpg Acquisition
BusinessCombinationsAdditionsRelatedToTPGAcquisition
0
CY2021 lfst Business Combination Addition Related To Acquisitions
BusinessCombinationAdditionRelatedToAcquisitions
10685000
lfst Business Combination Addition Related To Acquisitions
BusinessCombinationAdditionRelatedToAcquisitions
10220000
lfst Business Combination Addition Related To Acquisitions
BusinessCombinationAdditionRelatedToAcquisitions
3788000
CY2021 lfst Business Combinations Payments Of Contingent Consideration
BusinessCombinationsPaymentsOfContingentConsideration
-12279000
lfst Business Combinations Payments Of Contingent Consideration
BusinessCombinationsPaymentsOfContingentConsideration
-4291000
lfst Business Combinations Payments Of Contingent Consideration
BusinessCombinationsPaymentsOfContingentConsideration
-19093000
CY2021 lfst Business Combination Losses On Remeasurement
BusinessCombinationLossesOnRemeasurement
2610000
lfst Business Combination Losses On Remeasurement
BusinessCombinationLossesOnRemeasurement
576000
lfst Business Combination Losses On Remeasurement
BusinessCombinationLossesOnRemeasurement
-322000
CY2021Q4 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
17430000
CY2020Q4 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
16414000
CY2020Q2 lfst Business Combination Contingent Considerations
BusinessCombinationContingentConsiderations
9909000
CY2021 lfst Operating Leases Expiration Year
OperatingLeasesExpirationYear
2031
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
32630000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
11378000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4210000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7510000
CY2021 us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
2000000
CY2021 us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
4000000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-343947000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13125000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
327523
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
302335
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.05
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04

Files In Submission

Name View Source Status
0000950170-22-004096-index-headers.html Edgar Link pending
0000950170-22-004096-index.html Edgar Link pending
0000950170-22-004096.txt Edgar Link pending
0000950170-22-004096-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img22768366_0.jpg Edgar Link pending
lfst-20211231.htm Edgar Link pending
lfst-20211231.xsd Edgar Link pending
lfst-20211231_cal.xml Edgar Link unprocessable
lfst-20211231_def.xml Edgar Link unprocessable
lfst-20211231_htm.xml Edgar Link completed
lfst-20211231_lab.xml Edgar Link unprocessable
lfst-20211231_pre.xml Edgar Link unprocessable
lfst-ex10_4.htm Edgar Link pending
lfst-ex21_1.htm Edgar Link pending
lfst-ex23_1.htm Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
lfst-ex4_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending